MDS - Myelodysplastic syndrome

  1. A Phase 1b, multi-arm, open-label study of PDR001 and/or MBG453 in combination with decitabine in patients with acute myeloid leukemia or high risk myelodysplastic syndrome.
    Primary researcher: Kimmo Porkka
 

 Contact information

 
haluantutkimuspotilaaksi@hus.fi
tel. +358 50 427 0680